27. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber

Abstracts (HTML) List of Authors

Obermayer-Pietsch, B

Association of common SNPs of genes regulating vitamin D homoeostasis with vitamin D levels and liver fibrosis in a cohort of patients with chronic liver disease
Serum 25-hydroxy-vitamin D3 in chronic liver disease: a transient elastography- based study

Ocker, M

The HDAC inhibitor Panobinostat induce differentiation and reduce de-differentiation in human hepatoma xenografts
The pan-deacetylase inhibitor panobinostat (LBH 589) inhibits DNA methyltransferases in HCC in vitro and in vivo
Different expression pattern of stem cell markers in xenografts of human biliary tract cancer cell lines
Involvement of autophagy related factors in liver cancer cells after treatment with panobinostat
The kinase inhibitor DMAT reduces experimental HCC growth in mice
Differential expression of PPARalpha, STAT1 and STAT3 in TAA/EtOH-induced liver fibrosis in cannabinoid recepetor 1 knockout mice

Odenthal, M

Keratin 8 Variants are Associated with Cryptogenic Hepatitis
A novel non-MHC-I restricted CTL effector function mediated by TNF and XIAP
The tumor suppressor, miR-198, affects central pathways in tumorigenesis and in the immune response of hepatocellular carcinoma cells
Hepatitis E Virus in LeberBiopsien von Patienten mit akuter Hepatitis unbekannter Ätiologie
Hepatocyte growth factor (HGF) acts as an antifibrotic mediator by prominent miRNA-29 induction
New targets of miR-29 in cell communication during liver fibrogenesis
The pluripotency factor LIN28 is targeted by neuronal microRNAs participating in myofibroblastic differentiation

Oefner, P

Expression and function of methylthioadenosine phosphorylase (MTAP) in chronic liver disease

Oefner, PJ

Investigation of early proteomic changes in liver affected by non-alcoholic steatohepatitis
Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy
Mass spectrometry based metabolomics to study the development of Non-alcoholic steatohepatitis

Oertel, M

Activin A resistant fetal liver stem/progenitor cells (FLSPC) vigorously repopulate aging rat liver through augmented cell competition

Oh, J

Vergleich der transienten Elastografie (TE) mit dem Acoustic Radiation Force Impulse Imaging (ARFI) bei Kindern

Olbrich, A

Einfluss des CCR5D32 Genotyps auf spontanen Verlauf der HCV-Infektion und prädiktiven Wert des IL28B-Polymorphismus in der Ostdeutschen Anti-D-Kohorte

Oldenburg, J

Der rs12979860 C/T-Polymorphismus des IL28B-Gen beeinflusst die Progression der Leberfibrose bei HIV positiven Patienten mit HCV Genotyp 1 Koinfektion

Omary, MB

Non-coding keratin variants associate with fibrosis progression in hemochromatosis patients
Verlust von Keratin 19 prädisponiert zur Entwicklung einer cholestatischen Erkrankung
Human keratin 8 variants predispose to acetaminophen toxicity

Ommer, K

The tumor suppressor, miR-198, affects central pathways in tumorigenesis and in the immune response of hepatocellular carcinoma cells

Oniangue-Ndza, C

Protection from persistent hepatitis C virus infection by HLA class I: The need for multiple escape mutations in immunodominant T cell epitopes is a common feature

Othman, A

Hepatic differentiation of adipose-derived mesenchymal stem cells reduces recruitment of immune cells after transplantation into livers of CCl4 treated mice

Ott, M

Characterisation of Adult Liver Derived Progenitor Cells (ALDPC) and use for cell therapy and in vitro drug testing
Murine CD47 expressed on the surface of human hepatocytes protects from murine macrophage action in vitro and in vivo
Overexpression of Pitx2 induces morphological changes in Adult Liver Derived Progenitor Cells (ALDPC)

Otto, G

Charakteristika des Hepatozellulären Karzinoms (HCC) bei jungen Patienten aus einem großen deutschen Kollektiv
Einfluss des CYP2D6 Poor metabolizer Status auf die Fibroseprogression nach Lebertransplantation
Multi kinase inhibitor Sorafenib modulates cytokine secretion by HCC and liver tissue

Oude Elferink, R

Ein biliärer HCO3- Schirm schützt humane Cholangiozyten vor Gallensäuren-induziertem Zellschaden
Autotaxin spiegelt das Therapieansprechen bei cholestatischem Pruritus wider
Erhöhte Autotaxin-Serumaktivität ist spezifisch für cholestatischen Pruritus